MERUS LABS INTERNATIONAL INC. ANNOUNCES LISTING WITH THE CANADIAN NATIONAL
STOCK EXCHANGE

The Canadian National Stock Exchange has not approved nor disapproved the contents of this press release.

CNSX Symbol: MR

VANCOUVER, Sept. 15 /CNW/ - Merus Labs International Inc. ("Merus") is pleased to announce that effective at the open of market on Thursday, September 16, 2010, Merus' shares will begin trading on the Canadian National Stock Exchange ("CNSX") under the trading symbol MR.  The shares will be quoted on the CNSX in Canadian currency.

Merus' stock information including Bid and Ask prices will be available on the CNSX website at www.cnsx.ca.

"Listing of our shares on the CNSX is a significant achievement which will greatly facilitate our ability to reach the broader retail and institutional investors across Canada as well as significantly enhance our access to capital. On behalf of the management and the board of directors I want to thank our shareholders, partners and professional advisors for their support towards the completion of our listing on the CNSX." said Ahmad Doroudian, President and CEO.

About Merus Labs International Inc.

Merus is a specialty pharmaceutical company engaged in acquisition and licensing of pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and United States. Merus further enhances the sale and distribution of these products by introduction of a focused marketing and promotion plan.  

For further information: